The complement system in NMOSD and MG: A target for therapeutic benefit?

touchPANEL DISCUSSION for touchIMMUNOLOGY

Listen to a panel of leading experts discuss  the evidence for complement involvement in the pathogenesis of neuromyelitis optica spectrum disorder and myasthenia gravis, review the markers of complement activation, and highlight the implications of the latest data for complement therapeutics for practice.

The experts

• Prof. Said Beydoun, Keck School of Medicine of USC, Los Angeles, CA, USA
• Prof. Heinz Wiendl, University Hospital Münster, Münster, Germany
• Dr Pushpa Narayanaswami, Beth Israel Deaconess Medical Center, Boston, MA, USA

This touchPODCAST is for HCPs only.

An independent medical education grant from Alexion Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: touchIMMUNOLOGY